clinical trial · NCT00647751
Food Study of Lamotrigine Tablets 25 mg to Lamictal® Tablets 25 mg
HealthyLamotrigine Tablets 25 mgLamictal® Tablets 25 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's lamotrigine 25 mg tablets to GlaxoSmithKline's (GSK) Lamictal® 25 mg tablets following a single, oral 50 mg (2 x 25 mg) dose administration under fed conditions.
started
Aug 1, 2004
primary completion
Aug 1, 2004
completion
Aug 1, 2004
last updated
Apr 24, 2024
official title
Single-Dose Food In Vivo Bioequivalence Study of Lamotrigine Tablets (25 mg; Mylan) to Lamictal® Tablets (25 mg; GSK) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol